These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7859200)

  • 1. What happens to donated blood?
    Robinson A
    CMAJ; 1995 Feb; 152(4):521-4. PubMed ID: 7859200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
    Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
    Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV retrospective study of the German Red Cross blood donation service in Germany].
    Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
    Panhotra BR; Al-Bahrani A; Ul-Hassan Z
    Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
    Diro E; Alemu S; G/Yohannes A
    Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
    Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
    Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of HIV infection from blood transfusion in Montreal.
    Remis RS; Delage G; Palmer RW
    CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.
    Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E
    CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous bacterial contamination of donor blood.
    Rock G; Westwood JC
    Can Med Assoc J; 1977 May; 116(9):988-91. PubMed ID: 322833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-reactive microbiologic screening test results in Swedish blood donors-how big is the problem? A survey among blood centers and deferred donors.
    Tynell E; Norda R; Ekermo B; Sanner M; Andersson S; Björkman A
    Transfusion; 2007 Jan; 47(1):80-9. PubMed ID: 17207234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Red Cross blood transfusion service.
    Penner DW
    Pathologist; 1979 Feb; 33(2):90-1. PubMed ID: 10240258
    [No Abstract]   [Full Text] [Related]  

  • 20. Computer-based interview for screening blood donors for risk of HIV transmission.
    Locke SE; Kowaloff HB; Hoff RG; Safran C; Popovsky MA; Cotton DJ; Finkelstein DM; Page PL; Slack WV
    JAMA; 1992 Sep; 268(10):1301-5. PubMed ID: 1507376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.